Edgewise Therapeutics, Inc. · NASDAQ:EWTX

Paradigm Biocapital Advisors LP reported a 9.50% stake in Edgewise Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 14, 2026

Paradigm Biocapital Advisors LP reported a 9.50% stake in Edgewise Therapeutics, Inc., 10,215,455 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).

Stake
9.50%
Shares
10,215,455
Intent
Passive
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
Paradigm BioCapital Advisors LP9.50%10,215,455
Paradigm BioCapital Advisors GP LLC9.50%10,215,455
Senai Asefaw, M.D.9.50%10,215,455
Paradigm BioCapital International Fund Ltd.8.30%8,961,631

Source

View original at SEC

Related